Evaluating a Nurse-Led Dialysis Self-Management Program to Reduce Distress in Hemodialysis Patients A Randomized Controlled Trial
Led by Kutahya Health Sciences University · Updated on 2026-08-13
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a nurse-led self-management program designed to reduce distress related to dialysis in adults receiving hemodialysis. This trial is a randomized controlled study comparing the effects of this program plus routine care against routine hemodialysis care alone. The goal is to see if the program can improve patients ability to manage their treatment and reduce associated stress and uncertainty.
The program lasts six weeks and involves weekly face-to-face sessions with a nurse, each lasting about 40 to 45 minutes. It combines standard education on dialysis with personalized counseling that addresses individual needs such as fluid and diet management, medication adherence, symptom control, and coping with treatment uncertainty. Participants in the control group continue with their usual hemodialysis care without additional education or counseling from the research team.
Participants will be assessed at the start, after 6 weeks, and again at 18 weeks. Researchers will measure dialysis-related distress, uncertainty about illness and treatment, and treatment adherence through questionnaires and clinical indicators. The programs delivery will be monitored for quality using a standardized checklist. The total involvement spans at least 18 weeks including follow-up assessments.
CONDITIONS
Brief Title
Nurse-Led Dialysis Self-Management Program for Hemodialysis Distress
Research Team
S
Serkan Budak, PhD / RN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Receiving hemodialysis treatment for at least 3 months
Receiving hemodialysis treatment at least twice per week
Able to read and understand Turkish
Conscious and able to communicate
Providing written informed consent
You will not qualify if you...
Advanced cognitive impairment
Active psychiatric crisis
History of major surgery or acute severe illness within the last 3 months
Planned kidney transplantation in the near future
Serious physical or communication problems that may prevent regular participation in the intervention sessions
Concurrent participation in another structured education or psychosocial intervention program
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - 6 weeks
Participants receive either the nurse-led dialysis self-management program plus routine hemodialysis care or continue routine hemodialysis care alone.
Weekly face-to-face sessions lasting 40 to 45 minutes for intervention group
Follow-up
Duration - Up to 18 weeks from baseline
Participants are assessed for dialysis-related distress, treatment adherence, and illness uncertainty at 6 weeks and 18 weeks after starting the program.
Assessments at baseline, 6 weeks, and 18 weeks
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Study of Thyroid Hormone Treatment With Levothyroxine in Adults on Hemodialysis to Improve Quality of Life and Heart Health
Evaluating Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in End-Stage Renal Disease Patients
Study of Alirocumab Given Every Two Weeks for 12 Weeks in Adults on Stable Hemodialysis or Peritoneal Dialysis
Evaluating the Effects of Repeated Ischemic Preconditioning on Blood Pressure and Inflammation in Adults with Chronic Kidney Disease Undergoing Hemodialysis or Non-Dialysis Care
Bioimpedance Spectroscopy Analysis to Measure Fluid Changes in Hemodialysis Patients
Comparing Iron Treatment Approaches Using Reticulocyte Hemoglobin Equivalent or Transferrin Saturation in Adults on Hemodialysis with Anemia
International Study to Monitor Arteriovenous Access in Adults on Hemodialysis Using the PatenSee Contactless Optical Device
DIALysis With EXpanded Solute Removal Trial Evaluating Health Effects of Newer Hemodialysis Filters Compared to Conventional High-Flux Hemodialysis
Study of Polymethylmethacrylate Dialysis Membranes to Reduce Itching and Improve Quality of Life in Patients on Maintenance Hemodialysis
Study of Different Magnesium Levels in Citrate Dialysate During Hemodialysis to Understand Blood Cell Activation and Inflammation
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Development process, clinical utility, and preliminary psychometric evidence of a new tool for screening psychological distress in renal care settings: the Hemodialysis Distress Thermometer (HD-DT).